These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 10364038

  • 1. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
    Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA.
    Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
    [Abstract] [Full Text] [Related]

  • 2. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL.
    Orv Hetil; 2006 Jan 29; 147(4):175-81. PubMed ID: 16515026
    [Abstract] [Full Text] [Related]

  • 3. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF.
    Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898
    [Abstract] [Full Text] [Related]

  • 4. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J, Stenling R, Palmqvist R, Rutegård J.
    J Pediatr Gastroenterol Nutr; 2008 May 27; 46(5):534-8. PubMed ID: 18493208
    [Abstract] [Full Text] [Related]

  • 5. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.
    Marchesa P, Lashner BA, Lavery IC, Milsom J, Hull TL, Strong SA, Church JM, Navarro G, Fazio VW.
    Am J Gastroenterol; 1997 Aug 27; 92(8):1285-8. PubMed ID: 9260790
    [Abstract] [Full Text] [Related]

  • 6. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
    Loftus EV, Aguilar HI, Sandborn WJ, Tremaine WJ, Krom RA, Zinsmeister AR, Graziadei IW, Wiesner RH.
    Hepatology; 1998 Mar 27; 27(3):685-90. PubMed ID: 9500695
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
    Terg R, Sambuelli A, Coronel E, Mazzuco J, Cartier M, Negreira S, Muñoz A, Gil A, Miguez C, Huernos S, Romero G, Goncalvez S, Levi D, Abecasis R.
    Acta Gastroenterol Latinoam; 2008 Mar 27; 38(1):26-33. PubMed ID: 18533354
    [Abstract] [Full Text] [Related]

  • 8. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Mar 27; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 9. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
    D'Haens GR, Lashner BA, Hanauer SB.
    Am J Gastroenterol; 1993 Aug 27; 88(8):1174-8. PubMed ID: 8338083
    [Abstract] [Full Text] [Related]

  • 10. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM, Loftus EV, Sandborn WJ, Bryant SC, Smyrk TC.
    Gut; 2009 Sep 27; 58(9):1226-33. PubMed ID: 19251712
    [Abstract] [Full Text] [Related]

  • 11. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
    Joo M, Abreu-e-Lima P, Farraye F, Smith T, Swaroop P, Gardner L, Lauwers GY, Odze RD.
    Am J Surg Pathol; 2009 Jun 27; 33(6):854-62. PubMed ID: 19295408
    [Abstract] [Full Text] [Related]

  • 12. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
    Marelli L, Xirouchakis E, Kalambokis G, Cholongitas E, Hamilton MI, Burroughs AK.
    Gut; 2011 Sep 27; 60(9):1224-8. PubMed ID: 21402617
    [Abstract] [Full Text] [Related]

  • 13. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW.
    Surgery; 2005 Oct 27; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [Abstract] [Full Text] [Related]

  • 14. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis.
    Navaneethan U, Venkatesh PG, Mukewar S, Lashner BA, Remzi FH, McCullough AJ, Kiran RP, Shen B, Fung JJ.
    Clin Gastroenterol Hepatol; 2012 May 27; 10(5):540-6. PubMed ID: 22245961
    [Abstract] [Full Text] [Related]

  • 15. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U, Kochhar G, Venkatesh PG, Lewis B, Lashner BA, Remzi FH, Shen B, Kiran RP.
    Gastrointest Endosc; 2012 May 27; 75(5):1045-1054.e1. PubMed ID: 22405258
    [Abstract] [Full Text] [Related]

  • 16. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
    Wolf JM, Rybicki LA, Lashner BA.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):783-8. PubMed ID: 16225486
    [Abstract] [Full Text] [Related]

  • 17. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
    Navaneethan U, Venkatesh PG, Lashner BA, Shen B, Kiran RP.
    Aliment Pharmacol Ther; 2012 May 01; 35(9):1045-53. PubMed ID: 22428605
    [Abstract] [Full Text] [Related]

  • 18. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
    Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB.
    Clin Gastroenterol Hepatol; 2006 Nov 01; 4(11):1346-50. PubMed ID: 17059900
    [Abstract] [Full Text] [Related]

  • 19. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L, Lapidus A, Ost A, Bergquist A.
    Dis Colon Rectum; 2011 Nov 01; 54(11):1392-7. PubMed ID: 21979184
    [Abstract] [Full Text] [Related]

  • 20. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B, Halliday J, Aryasingha S, Sharifi Y, Checchin D, Warren BF, Kitiyakara T, Travis SP, Chapman RW.
    Clin Gastroenterol Hepatol; 2012 Mar 01; 10(3):303-8. PubMed ID: 22037429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.